teuro 10.000 i.e. (100 mg)/1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
laboratorios farmaceuticos rovi, s.a. - natrijev enoksaparinat - raztopina za injiciranje - natrijev enoksaparinat 100 mg / 1 ml - enoksaparin
teuro 4.000 i.e. (40 mg)/0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
laboratorios farmaceuticos rovi, s.a. - natrijev enoksaparinat - raztopina za injiciranje - natrijev enoksaparinat 40 mg / 1 ml - enoksaparin
teuro 6.000 i.e. (60 mg)/0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
laboratorios farmaceuticos rovi, s.a. - natrijev enoksaparinat - raztopina za injiciranje - natrijev enoksaparinat 60 mg / 1 ml - enoksaparin
teuro 8.000 i.e. (80 mg)/0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
laboratorios farmaceuticos rovi, s.a. - natrijev enoksaparinat - raztopina za injiciranje - natrijev enoksaparinat 80 mg / 0,8 ml - enoksaparin
teuro 2.000 i.e. (20 mg)/0,2 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
laboratorios farmaceuticos rovi, s.a. - natrijev enoksaparinat - raztopina za injiciranje - natrijev enoksaparinat 20 mg / 1 ml - enoksaparin
bivalirudin accord 250 mg prašek za koncentrat za raztopino za injiciranje/infundiranje
accord healthcare - bivalirudin - prašek za koncentrat za raztopino za injiciranje/infundiranje - bivalirudin 250 mg / 1 viala - bivalirudin
revasc
canyon pharmaceuticals ltd. - desirudin - venska tromboza - antitrombotična sredstva - preprečevanje globoke venske tromboze pri bolnikih, ki so v postopku izbirnega kirurškega substitucijskega kolka ali kolena.
xarelto
bayer ag - rivaroksaban - arthroplasty, replacement; venous thromboembolism - antitrombotična sredstva - xarelto, co-daje z acetilsalicilne kisline (asa) samostojno ali s asa plus clopidogrel ali ticlopidine, je označen za preprečevanje atherothrombotic dogodkov pri odraslih bolnikih po akutni koronarni sindrom (acs) s povišano srčno biomarkerje. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. preprečevanje venska trombembolija (vte) pri odraslih bolnikih, ki so v postopku izbirni kirurški zamenjavi kolka ali kolena. zdravljenje globoke venske tromboze (dvt) in pljučna embolija (pe), in preprečevanje ponavljajočih se dvt in pe pri odraslih. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
dexxience
portola pharma uk limited - betrixaban maleate - venska tromboembolija - antitrombotična sredstva - preprečevanje venske thromboembolism.
vinpocetin covex 10 mg tablete
vinpocetin - tableta - vinpocetin 10 mg / 1 tableta - vinpocetin